No one could claim that the reported amount of revenues is anything less than disappointing. I have a feeling this, and the previous, sums are "managed" rather than genuine formulaic achievements based on sales. The report contains the same use of the word increasing when talking about future Fruitflow projects, and the widening of health application is highly important to the future. For the record, 2014 wasn't our year IMHO. Progress was made, and some income to offset costs began, insufficient to make any big difference though. We move forward, hoping for bigger launches, better promotion -new video will help- and further news on cognitive function and blood pressure reduction. Our new poster is none other than the one who flounced off around a month ago. He or she should simply grow up.
Dismal RNS jonesy229 ?. Reduction of set/producton up costs. Still lots of interest from all Global markets. New promotional video due in 2015. Results and publication of recent studies. Trials for studies in fruitflow for reducing blood pressure. I see this as all good. There are lots of other AIM shares that don't have these positive things and are trading far higher than what they should be or have been pumped and dumped I.e. TRP, KEA, and left share holders with nothing. I do agree the SP is very disappointing but the outlook does look promising and I am sure the MM will push the SP up during 2015. I am holding and will add as funds from other shares I hold hopefully come good.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.